TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36462782

Group type: EXPERIMENTAL
Intervention: Lateral extra-articular procedures (LEAPs) performed concomitant to anterior cruciate ligament reconstruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Lemaire technique added to anterior cruciate ligament reconstruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iliotibial band based technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory studies on iliotibial band based procedures
Number of subjects: 0
Study: 32434237

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate combined with levobupivacaine periarticular cocktail (20 mL of magnesium sulfate 250 mg + levobupivacaine 50 mg + triamcinolone 25 mg + 0.9% normal saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levobupivacaine periarticular cocktail (20 mL of levobupivacaine 50 mg + triamcinolone 25 mg + 0.9% normal saline)
Number of subjects: 60
Study: 33406735

Group type: EXPERIMENTAL
Intervention: PCA + TEAS
Number of subjects: 71

Group type: COMPARATOR
Intervention: PCA + sham-TEAS
Number of subjects: 71

Group type: COMPARATOR
Intervention: PCA only
Number of subjects: 71
Study: 33020647

Group type: EXPERIMENTAL
Intervention: LV20.19 CAR T cells (2.5 × 106 cells per kg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LV20.19 CAR T cells (various doses)
Number of subjects: 22
Study: 34384345

Group type: COMPARATOR
Intervention: Resisted training
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 56
Study: 33758158

Group type: EXPERIMENTAL
Intervention: Increased Bacteroides fragilis
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Phenylacetylglutamine
Number of subjects: 402
Study: 32753113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low dose (bolus 10 mg kg−1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low dose + maintenance (bolus 10 mg kg−1 + maintenance 1 mg kg−1 hr−1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High dose (bolus 30 mg kg−1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High dose + maintenance (bolus 30 mg kg−1 + maintenance 3 mg kg−1 hr−1)
Number of subjects: 200
Study: 32572490

Group type: EXPERIMENTAL
Intervention: ePRO smartphone app for RA (RA App v.1.0) with daily notifications regarding ePROs
Number of subjects: 78
Study: 35352593

Group type: EXPERIMENTAL
Intervention: tolcapone 300 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: tolcapone 600 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: tolcapone (both dosages)
Number of subjects: 9
Study: 33712644

Group type: EXPERIMENTAL
Intervention: Ultrasound (22.4 kHz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 0
Study: 32022106

Group type: EXPERIMENTAL
Intervention: Vida Ativa Melhorando a Saúde
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 35289182

Group type: EXPERIMENTAL
Intervention: Time in target range (TTR) for systolic blood pressure (SBP) defined as 110 to 130 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TTR groups
Number of subjects: 0
Study: 34057796

Group type: EXPERIMENTAL
Intervention: Novel point-of-care lateral flow diagnostic test for detecting bacterial proteases
Number of subjects: 266
Study: 34402044

Group type: EXPERIMENTAL
Intervention: Facemask oxygen (15 l.min-1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (50 l.min-1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen plus mouthpiece (50 l.min-1 + 15 l.min-1)
Number of subjects: 84
Study: 33905536

Group type: EXPERIMENTAL
Intervention: CIM consultation plus information leaflet
Number of subjects: 291
Study: 33357789

Group type: EXPERIMENTAL
Intervention: Gender equality-based reproductive health education
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 135
Study: 35050518

Group type: EXPERIMENTAL
Intervention: Youth Empowerment Solutions (YES) program
Number of subjects: 329
Study: 34083328

Group type: EXPERIMENTAL
Intervention: Demonstrate and distribute OraQuick HIV self-testing kits (HIVST)
Number of subjects: 6909

Group type: EXPERIMENTAL
Intervention: Perform pinprick HIV testing (H2H)
Number of subjects: 6909

Group type: EXPERIMENTAL
Intervention: Offer a choice to either receive HIVST or H2H
Number of subjects: 6909

Group type: COMPARATOR
Intervention: Standard care (nurses counsel and refer to health facilities)
Number of subjects: 6909
Study: 35268055

Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after meals with different carbohydrate content (0.75 or 1.5 g of CHO per kg/body weight)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after consuming a mixed meal or a CHO drink matched for absolute CHO content (75 g)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after lower CHO content meals
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30 min of brisk walking after a mixed meal or a CHO drink
Number of subjects: 21
Study: 33305662

Group type: EXPERIMENTAL
Intervention: Cabergoline combined with hormone therapy standard schemes
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 227
Study: 36089471

Group type: EXPERIMENTAL
Intervention: ChAdOx1/mRNA-1273 8 weeks apart
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: mRNA-1273/mRNA-1273 4 weeks apart
Number of subjects: 399
Study: 33308427

Group type: COMPARATOR
Intervention: Monovalent OPV2
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: High-dose novel OPV2-c1
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Low-dose novel OPV2-c1
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: High-dose novel OPV2-c2
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Low-dose novel OPV2-c2
Number of subjects: 834
Study: 36468784

Group type: EXPERIMENTAL
Intervention: Closed-loop automated insulin delivery (MiniMed 670G)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 21
Study: 33230718

Group type: EXPERIMENTAL
Intervention: Intensive toilet training session (2-hour training on two consecutive days in small groups)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (parents encouraged to start toilet training in their own manner)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive toilet training session
Number of subjects: 0
Study: 35791704

Group type: EXPERIMENTAL
Intervention: Dexpanthenol ampoule 250 mg/2 ml and biotin ampoule 5 mg/1 ml (Pars Behvarzan)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dexpanthenol ampoule 250 mg/2 ml and biotin ampoule 5 mg/1 ml (Bayer Company)
Number of subjects: 50
Study: 32157691

Group type: EXPERIMENTAL
Intervention: Sleep restriction (6.5 hr in bed)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sleep extension (9.5 hr in bed)
Number of subjects: 48
Study: 35334797

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (75 mg of Cr monohydrate·kg−1·day−1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo supplementation (75 mg of glucose·kg−1·day−1)
Number of subjects: 16
Study: 33559067

Group type: EXPERIMENTAL
Intervention: Facilitated enrollment with dedicated outreach to encourage use of the PCD tool (PatientWisdom)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard pre-visit email
Number of subjects: 301
Study: 35428348

Group type: EXPERIMENTAL
Intervention: Alpha/Theta Neurofeedback
Number of subjects: 15
Study: 34704430

Group type: EXPERIMENTAL
Intervention: Ceratonia siliqua (Carob) capsules, 500 mg, taken daily for 90 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vitamin E capsules, taken three times a day for 90 days
Number of subjects: 50
Study: 35975547

Group type: EXPERIMENTAL
Intervention: High-dose AD109 (75/2.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose AD109 (37.5/2.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33735632

Group type: EXPERIMENTAL
Intervention: Enzymatic immunoassay test
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Liquid-liquid extraction method with LC-MS/MS
Number of subjects: 500

Group type: COMPARATOR
Intervention: Immunoassay screening tests
Number of subjects: 500
Study: 33338364

Group type: EXPERIMENTAL
Intervention: Early childhood caries (ECC) prevalence assessment
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Assessment of initial caries lesions
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by gender and language
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by parental employment
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by parental education
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by family income
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Comparison of disease frequency by ethnicity
Number of subjects: 341
Study: 34935139

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus capecitabine (GEMCAP)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Gemcitabine monotherapy (GEM)
Number of subjects: 778
Study: 32777552

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 55
Study: 34321048

Group type: EXPERIMENTAL
Intervention: 3 g/d whole meat GSM powder
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (sunflower seed protein)
Number of subjects: 50
Study: 36068945

Group type: EXPERIMENTAL
Intervention: Keverprazan 20 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Keverprazan 30 mg
Number of subjects: 180

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 180
Study: 34311022

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 195

Group type: COMPARATOR
Intervention: Sulphonylureas
Number of subjects: 195
Study: 32641337

Group type: EXPERIMENTAL
Intervention: FitSkills intervention (exercise with a student mentor at local gym for 1 hour, two times per week for 12 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control phase (no specific intervention details provided)
Number of subjects: 160
Study: 33439574

Group type: EXPERIMENTAL
Intervention: Nomogram incorporating serum neutrophil-to-lymphocyte ratio (NLR) as a predictor of spontaneous stone passage (SSP)
Number of subjects: 1186
Study: 33772947

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 412
Study: 32546963

Group type: EXPERIMENTAL
Intervention: Apatinib (750 mg daily from Day 9-21)
Number of subjects: 0
Study: 34687240

Group type: EXPERIMENTAL
Intervention: Do-it-yourself continuous glucose monitor (DIYrtCGM) with technical support
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Do-it-yourself continuous glucose monitor (DIYrtCGM)
Number of subjects: 11
Study: 33150424

Group type: EXPERIMENTAL
Intervention: Novel flyer with simple and positive framing
Number of subjects: 1070
Study: 32289853

Group type: EXPERIMENTAL
Intervention: Thrombin injection
Number of subjects: 68

Group type: COMPARATOR
Intervention: Glue injection
Number of subjects: 68
Study: 35291270

Group type: EXPERIMENTAL
Intervention: Low sodium high potassium (LSHP) diet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual diet (control)
Number of subjects: 70
Study: 34641839

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (including occupational therapy and reintegration consultation)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Cohort study for partners of cancer survivors
Number of subjects: 236
Study: 32169259

Group type: EXPERIMENTAL
Intervention: Sensorimotor exercises (three 60‐min sessions per week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33949031

Group type: EXPERIMENTAL
Intervention: School-based physical activity intervention
Number of subjects: 76
Study: 34238342

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) granules combined with chemotherapy
Number of subjects: 270

Group type: COMPARATOR
Intervention: Chemotherapy alone (placebo control)
Number of subjects: 270
Study: 35103766

Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (33‐34 °C; n=168)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Normothermia (36‐37 °C; n=166)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (33‐34 °C)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Normothermia (36‐37 °C)
Number of subjects: 374
Study: 32451125

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34719004

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg, twice daily)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 32029547

Group type: EXPERIMENTAL
Intervention: noninvasive vagus nerve stimulation (nVNS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: sham vagus nerve stimulation
Number of subjects: 21
Study: 36156108

Group type: EXPERIMENTAL
Intervention: Conventional nicotine with menthol
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Conventional nicotine cigarette with no menthol
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Cigarette with reduced nicotine (RNC) with menthol
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: RNC cigarette and no menthol
Number of subjects: 263

Group type: COMPARATOR
Intervention: Own brand of cigarette (conventional nicotine with menthol)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Non-menthol and/or RNC cigarettes
Number of subjects: 263
Study: 33928452

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (total number of B-lines)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inferior vena cava collapsibility index (cIVC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined use of lung ultrasound and cIVC
Number of subjects: 10
Study: 32437567

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg per day plus Biejia-Ruangan (BR) 2 g 3 times a day for 72 weeks
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg per day plus Biejia-Ruangan (BR)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 33691454

Group type: EXPERIMENTAL
Intervention: AcrySof® IQ Toric IOL
Number of subjects: 20

Group type: COMPARATOR
Intervention: AcrySof® IQ IOL with steep-axis incision
Number of subjects: 20
Study: 32572064

Group type: EXPERIMENTAL
Intervention: 1% bromelain-based whitening
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1% ficin-based whitening
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1% papain-based whitening
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 wt% carbamide peroxide (control)
Number of subjects: 40
Study: 35413886

Group type: EXPERIMENTAL
Intervention: Loading dose of 1.5-g meropenem resolved in 30-ml saline given via central line for 30 min, followed by 0.75-g meropenem every 8 h for 30 min.
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.75-g meropenem for 30 min every 8 h (Control group).
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Loading dose of 1.5-g meropenem.
Number of subjects: 120
Study: 33855805

Group type: EXPERIMENTAL
Intervention: Iptakalim hydrochloride (ITKL) 5, 10, 15, and 20 mg single oral administration; 10 and 20 mg multiple oral administration
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 32891342

Group type: EXPERIMENTAL
Intervention: Tumescent technique
Number of subjects: 357

Group type: COMPARATOR
Intervention: Electrocautery technique
Number of subjects: 357
Study: 35385137

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study: 34441930

Group type: EXPERIMENTAL
Intervention: Immediate invasive treatment strategy (<3 h)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Early invasive treatment strategy (12–24 h)
Number of subjects: 249
Study: 35667715

Group type: EXPERIMENTAL
Intervention: Cevira (hexaminolevulinate photodynamic therapy)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 33204086

Group type: EXPERIMENTAL
Intervention: Titanium dioxide-coated stainless steel orthodontic wires
Number of subjects: 68

Group type: COMPARATOR
Intervention: Uncoated stainless steel orthodontic wires (Control)
Number of subjects: 68
Study: 33742550

Group type: EXPERIMENTAL
Intervention: Intermittently scanned continuous glucose monitoring system
Number of subjects: 0
Study: 35871148

Group type: EXPERIMENTAL
Intervention: Verbal guidance combined with a comic book (Intervention Group - IG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Verbal guidance by nurses (Control Group - CG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both IG and CG
Number of subjects: 120
Study: 34351693

Group type: EXPERIMENTAL
Intervention: Intralesional tuberculin immunotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 30
Study: 35527126

Group type: EXPERIMENTAL
Intervention: Diet plus physical activity
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Diet only
Number of subjects: 121

Group type: COMPARATOR
Intervention: Lean control group
Number of subjects: 121
Study: 33867298

Group type: EXPERIMENTAL
Intervention: Email survey alone
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Email survey + telephone reminder
Number of subjects: 72

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 72
Study: 34880074

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) after rituximab
Number of subjects: 39

Group type: COMPARATOR
Intervention: Rituximab monotherapy
Number of subjects: 39
Study: 33942655

Group type: EXPERIMENTAL
Intervention: 4F-PCC
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard of care therapies
Number of subjects: 58
Study: 32530900

Group type: EXPERIMENTAL
Intervention: Branching Path Simulation (BPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular Lectures (RL)
Number of subjects: 0
Study: 33025243

Group type: EXPERIMENTAL
Intervention: Zilver PTX drug-eluting stent (DES) treatment
Number of subjects: 2227

Group type: EXPERIMENTAL
Intervention: Example patient profiles
Number of subjects: 2227
Study: 33063619

Group type: EXPERIMENTAL
Intervention: Graphic warning messages campaign
Number of subjects: 1392
Study: 33665467

Group type: EXPERIMENTAL
Intervention: Personalized antibiotic prescription feedback and evidence-based treatment guidelines including region-specific antibiotic resistance information, provided quarterly for two years.
Number of subjects: 3426

Group type: EXPERIMENTAL
Intervention: Personalized antibiotic prescription feedback and evidence-based treatment guidelines.
Number of subjects: 3426

Group type: COMPARATOR
Intervention: Control group with no intervention.
Number of subjects: 3426
Study: 608561422

Group type: EXPERIMENTAL
Intervention: Community exposure to CHW integrated primary health-care services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHW programme introduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coordination with health system efforts
Number of subjects: 0
Study: 35700976

Group type: EXPERIMENTAL
Intervention: Individualized RTF-velocity relationships
Number of subjects: 23

Group type: COMPARATOR
Intervention: Generalized RTF-velocity relationships
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Velocity values associated with different RTFs
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Prediction of RTF under fatigue
Number of subjects: 23
Study: 34668671

Group type: EXPERIMENTAL
Intervention: Intervention pharmacies (pharmacist-led intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control pharmacies
Number of subjects: 0
Study: 32468883

Group type: EXPERIMENTAL
Intervention: Health education with mind mapping
Number of subjects: 159

Group type: COMPARATOR
Intervention: Health education without mind mapping (Control)
Number of subjects: 159
Study: 35841944

Group type: EXPERIMENTAL
Intervention: EHR-based LLT intensification alert
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2500
Study: 32820698

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 36012027

Group type: EXPERIMENTAL
Intervention: Culturally and linguistically appropriate food education program based on the Transtheoretical model, 10 weekly sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: General educational sessions on food and health, 3 sessions
Number of subjects: 0
Study: 33867498

Group type: EXPERIMENTAL
Intervention: AERO‐PA (aerobic training and increasing nonexercise physical activity)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AERO (aerobic training)
Number of subjects: 45

Group type: COMPARATOR
Intervention: CON (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Change in steps (AERO‐PA)
Number of subjects: 45
Study: 36165989

Group type: EXPERIMENTAL
Intervention: Sprint interval training at 0% incline
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Sprint interval training at 6% incline
Number of subjects: 65
Study: 33767062

Group type: EXPERIMENTAL
Intervention: Invasive strategy (e.g., percutaneous coronary intervention or coronary artery bypass graft)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative strategy with maximal medical management
Number of subjects: 0
Study: 32092887

Group type: COMPARATOR
Intervention: 400 IU daily vitamin D3
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: 4000 IU daily vitamin D3
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: 10,000 IU daily vitamin D3
Number of subjects: 373
Study: 35472115

Group type: EXPERIMENTAL
Intervention: Acellular Dermal Matrix (ADM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 20
Study: 33935080

Group type: EXPERIMENTAL
Intervention: BrainUp-10®
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 35850363

Group type: EXPERIMENTAL
Intervention: NBTXR3 (single intratumoral injection, volume equivalent to 10% of baseline tumor volume, at 53.3 g/L) plus external-beam RT (50 Gy in 25 fractions)
Number of subjects: 179

Group type: COMPARATOR
Intervention: External-beam RT alone (50 Gy in 25 fractions)
Number of subjects: 179
Study: 33511392

Group type: EXPERIMENTAL
Intervention: Whole-Slide Imaging (WSI)
Number of subjects: 171